Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments

• Tipo: Artigo em Revista Científica Internacional
• Data: 2019

Autores

Zannad, F (Autor) Outra; Ferreira, JP (Autor) FMUP; Pitt, B (Autor) Outra

Revista

Título: EUROPEAN HEART JOURNAL SUPPLEMENTS

Vol. 21

Páginas: A55-A60

ISSN: 1520-765X

Editora: Oxford University Press

Indexação

ISI Web of Knowledge - 10 Citações

Scopus - 9 Citações

Outras Informações

ID Authenticus: P-00Q-AN5

DOI: 10.1093/eurheartj/suy034

Abstract (EN): New therapeutic options to treat hyperkalaemia, such as potassium binders, have been suggested as potentially beneficial by allowing the maintenance (or increase) of the dose of medications that improve outcomes in several cardiovascular conditions, but which have in common the propensity for raising serum potassium. However, potassium binding drugs have yet to prove their causal association with improvements in patients' prognosis before their widespread use can be recommended. In this review we provided an up-to-dare appraisal on potassium binders, their potential clinical applications and directions for future research.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 6